City: Zeneca away
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.SO IT'S going to be all right after all. Bar some unexpected cataclysm in the stock market tomorrow morning, the pounds 1.3bn Zeneca rights issue, which has been struggling for weeks, looks like securing a reasonable level of take-up - 80 per cent plus. An embarrassing flop has been averted. The more difficult question to answer is whether demerger of ICI's pharmaceuticals division was the right thing in the first place. Sir Denys Henderson, who is now chairman of both Zeneca and the remaining ICI rump, regrets nothing. True, with the health care and pharmaceuticals sector now deeply unpopular, the demerger seems to have created little if any immediate shareholder value, but that was never the point, he insists.
The idea was to give the managements of the two companies fresh focus and direction in a rapidly changing world chemicals industry. If he's got it right, the added shareholder value will come naturally in the years ahead. Both Sweden's Procordia and Eastman Kodak of the US have recently announced similar demerger proposals. Imitation is the sincerest form of flattery, they say.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments